Literature DB >> 17591954

Phosphorylation of ephrin-B1 regulates dissemination of gastric scirrhous carcinoma.

Masamitsu Tanaka1, Reiko Kamata, Misato Takigahira, Kazuyoshi Yanagihara, Ryuichi Sakai.   

Abstract

Interaction of the Eph family of receptor protein tyrosine kinase and its ligand ephrin family induces bidirectional signaling via cell-cell contacts. High expression of B-type ephrin is frequently found in various cancer cells, and their expression levels are associated with high invasion of tumors and poor prognosis. However, whether ephrin-B1 actually promotes invasion of cancer cells in vivo has not been shown. We investigated the involvement of ephrin-B1 in regulating the invasiveness of scirrhous gastric cancer, which is a diffusely infiltrative carcinoma with high invasion potential. Reduction of ephrin-B1 expression by short inter-fering RNA or overexpression of phosphorylation-defective mutant suppressed migration and invasion of scirrhous gastric cancer cells in vitro without affecting tumor cell proliferation and apoptosis. Blocking of tyrosine phosphorylation of ephrin-B1 attenuates not only dissemination of cancer cells injected intraperitoneally but also local invasion and dissemination of orthotopically implanted cancer cells in the gastric wall of nude mice. Furthermore, blocking of ephrin-B1 phosphorylation attenuated the activation of Rac1 GTPase in these invasive gastric cancer cells. Our results suggest that tyrosine phosphorylation of ephrin-B1 promotes invasion of cancer cells in vivo and is a potential therapeutic target in some types of gastrointestinal cancers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17591954      PMCID: PMC1941588          DOI: 10.2353/ajpath.2007.070033

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Phosphorylation of ephrin-B1 via the interaction with claudin following cell-cell contact formation.

Authors:  Masamitsu Tanaka; Reiko Kamata; Ryuichi Sakai
Journal:  EMBO J       Date:  2005-10-06       Impact factor: 11.598

2.  Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway.

Authors:  Hyun-Shik Lee; Yong-Sik Bong; Kathryn B Moore; Kathleen Soria; Sally A Moody; Ira O Daar
Journal:  Nat Cell Biol       Date:  2005-12-18       Impact factor: 28.824

3.  Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands.

Authors:  S J Holland; N W Gale; G Mbamalu; G D Yancopoulos; M Henkemeyer; T Pawson
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

4.  Ephrin-B2 overexpression enhances integrin-mediated ECM-attachment and migration of B16 melanoma cells.

Authors:  Stefanie Meyer; Christian Hafner; Markus Guba; Stefanie Flegel; Edward K Geissler; Bernd Becker; Gudrun E Koehl; Evelyn Orsó; Michael Landthaler; Thomas Vogt
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

5.  Development and biological analysis of peritoneal metastasis mouse models for human scirrhous stomach cancer.

Authors:  Kazuyoshi Yanagihara; Misato Takigahira; Hiromi Tanaka; Teruo Komatsu; Hisao Fukumoto; Fumiaki Koizumi; Kazuto Nishio; Takahiro Ochiya; Yoshinori Ino; Setsuo Hirohashi
Journal:  Cancer Sci       Date:  2005-06       Impact factor: 6.716

6.  Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment.

Authors:  Matthias J E Arlt; Ilse Novak-Hofer; Daniela Gast; Verena Gschwend; Gerhard Moldenhauer; Jürgen Grünberg; Michael Honer; P August Schubiger; Peter Altevogt; Achim Krüger
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

7.  EphB receptor activity suppresses colorectal cancer progression.

Authors:  Eduard Batlle; Julinor Bacani; Harry Begthel; Suzanne Jonkheer; Suzanne Jonkeer; Alexander Gregorieff; Maaike van de Born; Núria Malats; Elena Sancho; Elles Boon; Tony Pawson; Steven Gallinger; Steven Pals; Hans Clevers
Journal:  Nature       Date:  2005-06-23       Impact factor: 49.962

Review 8.  The role of ephrins and Eph receptors in cancer.

Authors:  Hanna Surawska; Patrick C Ma; Ravi Salgia
Journal:  Cytokine Growth Factor Rev       Date:  2004-12       Impact factor: 7.638

9.  EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability.

Authors:  Masamitsu Tanaka; Reiko Kamata; Ryuichi Sakai
Journal:  J Biol Chem       Date:  2005-10-18       Impact factor: 5.157

10.  Interaction of rat ascites hepatoma cells with cultured mesothelial cell layers: a model for tumor invasion.

Authors:  H Akedo; K Shinkai; M Mukai; Y Mori; R Tateishi; K Tanaka; R Yamamoto; T Morishita
Journal:  Cancer Res       Date:  1986-05       Impact factor: 12.701

View more
  12 in total

1.  Complementary expression and repulsive signaling suggest that EphB receptors and ephrin-B ligands control cell positioning in the gastric epithelium.

Authors:  Kazushige Ogawa; Natsuki Takemoto; Maki Ishii; Elena B Pasquale; Takayuki Nakajima
Journal:  Histochem Cell Biol       Date:  2011-09-30       Impact factor: 4.304

Review 2.  Eph receptors and ephrins in cancer: bidirectional signalling and beyond.

Authors:  Elena B Pasquale
Journal:  Nat Rev Cancer       Date:  2010-03       Impact factor: 60.716

3.  Complementary expression of EphB receptors and ephrin-B ligand in the pyloric and duodenal epithelium of adult mice.

Authors:  Maki Ishii; Takayuki Nakajima; Kazushige Ogawa
Journal:  Histochem Cell Biol       Date:  2011-08-05       Impact factor: 4.304

4.  EphrinB1 expression is dysregulated and promotes oncogenic signaling in medulloblastoma.

Authors:  Nicole McKinney; Liangping Yuan; Hongying Zhang; Jingbo Liu; Yoon-Jae Cho; Elisabeth Rushing; Matthew Schniederjan; Tobey J MacDonald
Journal:  J Neurooncol       Date:  2014-09-26       Impact factor: 4.130

Review 5.  Making Connections: Guidance Cues and Receptors at Nonneural Cell-Cell Junctions.

Authors:  Ian V Beamish; Lindsay Hinck; Timothy E Kennedy
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-11-01       Impact factor: 10.005

6.  Aberrant EphB/ephrin-B expression in experimental gastric lesions and tumor cells.

Authors:  Shintaro Uchiyama; Noritaka Saeki; Kazushige Ogawa
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

7.  Tyrosine Phosphorylation Profiling Revealed the Signaling Network Characteristics of CAMKK2 in Gastric Adenocarcinoma.

Authors:  Mohd Altaf Najar; Mohammad Arefian; David Sidransky; Harsha Gowda; T S Keshava Prasad; Prashant Kumar Modi; Aditi Chatterjee
Journal:  Front Genet       Date:  2022-05-13       Impact factor: 4.772

8.  Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism.

Authors:  Jeffrey O Bush; Philippe Soriano
Journal:  Genes Dev       Date:  2009-06-10       Impact factor: 11.361

Review 9.  Recent results of therapy for scirrhous gastric cancer.

Authors:  Masahide Ikeguchi; Takanori Miyake; Tomoyuki Matsunaga; Manabu Yamamoto; Youji Fukumoto; Yosinori Yamada; Kenji Fukuda; Hiroaki Saito; Shigeru Tatebe; Shun-ichi Tsujitani
Journal:  Surg Today       Date:  2009-03-25       Impact factor: 2.549

10.  CUB-domain-containing protein 1 regulates peritoneal dissemination of gastric scirrhous carcinoma.

Authors:  Takamasa Uekita; Masamitsu Tanaka; Misato Takigahira; Yuri Miyazawa; Yukihiro Nakanishi; Yae Kanai; Kazuyoshi Yanagihara; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2008-05-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.